Articles By David Liew
Will a vegetarian diet and exercise actually help RA disease activity?
By David Liew
25 November 2022
The exact role of diet, physical activity, and stress management in the management of RA has long been debated. While reasonable evidence has supported the importance of physical activity in patients with RA, its capacity to reduce disease activity via conventional measures such as DAS28 was less well delineated.
Read Article
The spicy topic of turmeric in rheumatoid arthritis
By David Liew
14 November 2022
Curcumin, the active constituent of turmeric extract, has increasingly been promoted as a potential rheumatoid arthritis therapy, but data presented at ACR22 suggests that even in ideal situations, it is unable to do any better than placebo in replacing conventional RA therapies.
Read Article
Polymyalgia rheumatica: more than just steroids at ACR22
By David Liew
11 November 2022
After decades of having little else proven apart from glucocorticosteroids with which to treat polymyalgia rheumatica (PMR), evidence for steroid-sparing options has grown in recent years, and this crescendo is set to continue at ACR Convergence 2022 in Philadelphia, PA.
Read Article
Can we stop RA before it happens?
By David Liew
09 June 2022
Rheumatologists have long hoped and wondered whether the right type of early intervention could prevent rheumatoid arthritis occurring in at-risk individuals.
Read Article
Polymyalgia rheumatica immunological puzzle further illustrated
By David Liew
02 June 2022
Infiltrating macrophages expressing IL-6 and GM-CSF may drive the subacromial bursitis often seen in polymyalgia rheumatica, according to new research (abstract OP0015) prese
Read Article
Best of 2021: Israel provides COVID vaccine answers for rheumatic disease patients
By David Liew
28 December 2021
The question as to how autoimmune rheumatic disease patients fare with the COVID vaccine is one being asked in rheumatologists’ offices everywhere this year, and at the EULAR 2021 Virtual Congress, data presented from Israel, one of the first countries to vaccinate on a br
Read Article
Methotrexate and hepatic fibrosis: we must be doing something right
By David Liew
02 December 2021
Methotrexate may be a rheumatologist’s best friend, but a key part of counselling any patient about its use has always been the risk of hepatotoxicity.
Read ArticleMethotrexate and hepatic fibrosis: we must be doing something right
By David Liew
08 November 2021
Methotrexate may be a rheumatologist’s best friend, but a key part of counselling any patient about its use has always been the risk of hepatotoxicity.
Read Article
Can tender and swollen joint counts work in a telemedicine world?
By David Liew
08 November 2021
In a world where telemedicine and virtual care are not going away, is there value in patients assessing their own tender and swollen joints?
Read Article
Artificial intelligence brings clarity to early bony changes in inflammatory arthritis
By David Liew
16 June 2021
Subtle early bony changes in inflammatory arthritis can be hard even for experienced rheumatologists to interpret, even though they have traditionally been considered to become disease-defining as they progress.
Read Article